ÖZYİĞİT, G. Et Al. 2019. Castrate testosterone predicts biochemical relapse free survival in non-metastatic prostate cancer. 38th Annual Meeting of the European-Society-for-Radiotherapy-and-Oncology (ESTRO) , 440.

ÖZYİĞİT, G., HÜRMÜZ, P., YÜCE, D., & AKYOL, H. F., (2019). Castrate testosterone predicts biochemical relapse free survival in non-metastatic prostate cancer . 38th Annual Meeting of the European-Society-for-Radiotherapy-and-Oncology (ESTRO) (pp.440).

ÖZYİĞİT, GÖKHAN Et Al. "Castrate testosterone predicts biochemical relapse free survival in non-metastatic prostate cancer," 38th Annual Meeting of the European-Society-for-Radiotherapy-and-Oncology (ESTRO), 2019

ÖZYİĞİT, GÖKHAN Et Al. "Castrate testosterone predicts biochemical relapse free survival in non-metastatic prostate cancer." 38th Annual Meeting of the European-Society-for-Radiotherapy-and-Oncology (ESTRO) , pp.440, 2019

ÖZYİĞİT, G. Et Al. (2019) . "Castrate testosterone predicts biochemical relapse free survival in non-metastatic prostate cancer." 38th Annual Meeting of the European-Society-for-Radiotherapy-and-Oncology (ESTRO) , p.440.

@conferencepaper{conferencepaper, author={GÖKHAN ÖZYİĞİT Et Al. }, title={Castrate testosterone predicts biochemical relapse free survival in non-metastatic prostate cancer}, congress name={38th Annual Meeting of the European-Society-for-Radiotherapy-and-Oncology (ESTRO)}, city={}, country={}, year={2019}, pages={440} }